News & Updates
October is Breast Cancer Awareness Month
Thursday, October 10, 2024
October marks Breast Cancer Awareness Month, and Philly Fights Cancer remains committed to supporting the advancement of clinical trials and research aimed at improving cancer treatment, including breast cancer, at the Abramson Cancer Center (ACC).
Breast cancer is the most common cancer among women worldwide, with an estimated 1 in 8 women developing the disease in their lifetime. In the United States alone, over 280,000 new cases of invasive breast cancer are diagnosed each year. Early detection through regular screenings, such as mammograms, plays a critical role in improving outcomes, as it can identify cancer at an earlier, more treatable stage. Studies show that when breast cancer is detected early, the five-year survival rate exceeds 90%. Regular screening, coupled with advances in treatment, has contributed to a steady decline in breast cancer mortality rates, underscoring the vital importance of early detection in saving lives.
Abramson Cancer Center offers a comprehensive breast cancer program, encompassing screenings, specialized care, and access to cutting-edge clinical trials led by expert oncologists. Clinical trials are a cornerstone of medical innovation, providing patients with access to novel therapies that have the potential to improve outcomes while contributing to critical advancements in healthcare.
For more information on these essential clinical trials for breast cancer treatment, visit: https://www.pennmedicine.org/resear.../find-a-clinical-trial.
Share this post
October marks Breast Cancer Awareness Month, and Philly Fights Cancer remains committed to supporting the advancement of clinical trials and research aimed at improving cancer treatment, including breast cancer, at the Abramson Cancer Center (ACC).
Breast cancer is the most common cancer among women worldwide, with an estimated 1 in 8 women developing the disease in their lifetime. In the United States alone, over 280,000 new cases of invasive breast cancer are diagnosed each year. Early detection through regular screenings, such as mammograms, plays a critical role in improving outcomes, as it can identify cancer at an earlier, more treatable stage. Studies show that when breast cancer is detected early, the five-year survival rate exceeds 90%. Regular screening, coupled with advances in treatment, has contributed to a steady decline in breast cancer mortality rates, underscoring the vital importance of early detection in saving lives.
Abramson Cancer Center offers a comprehensive breast cancer program, encompassing screenings, specialized care, and access to cutting-edge clinical trials led by expert oncologists. Clinical trials are a cornerstone of medical innovation, providing patients with access to novel therapies that have the potential to improve outcomes while contributing to critical advancements in healthcare.
For more information on these essential clinical trials for breast cancer treatment, visit: https://www.pennmedicine.org/resear.../find-a-clinical-trial.